Skye Bioscience to Participate in Upcoming Healthcare Investment Conferences
PremiumPress ReleasesSkye Bioscience to Participate in Upcoming Healthcare Investment Conferences
25d ago
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Premium
Press Releases
Skye Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
27d ago
Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity
Premium
Press Releases
Skye Bioscience Launches Phase 2 CBeyond Clinical Trial of its Differentiated CB1 Inhibitor, Nimacimab, in Patients with Obesity
29d ago
Skye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” and Details Phase 2 Nimacimab Clinical Trial Design Including Obstructive Sleep Apnea Exploratory Endpoints
PremiumPress ReleasesSkye Bioscience Hosts Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” and Details Phase 2 Nimacimab Clinical Trial Design Including Obstructive Sleep Apnea Exploratory Endpoints
2M ago
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
Premium
The Fly
B. Riley reiterates Buy on Altimmune, Arrowhead after danuglipron given nod
2M ago
Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th
Premium
Press Releases
Skye Bioscience to Host Virtual KOL Event, “Metabolic Rewiring with CB1 Inhibition,” on July 24th
2M ago
Skye Bioscience Board Reshuffle and Strategic Leadership Strengthening
PremiumCompany AnnouncementsSkye Bioscience Board Reshuffle and Strategic Leadership Strengthening
3M ago
Skye Bioscience appoints Karen Smith to the Board
Premium
The Fly
Skye Bioscience appoints Karen Smith to the Board
3M ago
Skye Bioscience Appoints Dr. Karen Smith to Board of Directors
Premium
Press Releases
Skye Bioscience Appoints Dr. Karen Smith to Board of Directors
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100